(Q46841477)

English

Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Saito M

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Takada M

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Hirooka K

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Isobe F

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Yasumura Y

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Journal of Clinical Pharmacy and Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

30

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

603-610

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

ALDOSTERONE AND ITS ANTAGONISTS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Computer analysis of epidemiologic data on effect of drugs on hospital patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Angiotensin II receptor antagonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Hyperkalemia in Outpatients Using Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

DRUG SURVEILLANCE UTILISING NURSE MONITORS An Epidemiological Approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Assessment of adverse reactions within a drug surveillance program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Comprehensive drug surveillance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2005.00694.X

21 January 2018

Identifiers

10.1111/J.1365-2710.2005.00694.X

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16336294

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46841477&oldid=2134468869"